...
首页> 外文期刊>Archiv der Pharmazie >Synthesis, cytotoxic properties and tubulin polymerization inhibitory activity of novel 2-pyrazoline derivatives
【24h】

Synthesis, cytotoxic properties and tubulin polymerization inhibitory activity of novel 2-pyrazoline derivatives

机译:新型2-吡唑啉衍生物的合成,细胞毒性和微管蛋白聚合抑制活性

获取原文
获取原文并翻译 | 示例

摘要

A series of novel 1-(3',4',5'-trimethoxybenzoyl)-3,5-diarylpyrazoline derivatives were synthesized and evaluated for their cytotoxic properties on different cancer cell lines and tubulin polymerization inhibitory activity. Compounds 6d and 6e exhibited remarkable cytotoxic activity against different cancer cell lines with good tubulin polymerization inhibitory activity. Compound 6d exhibited moderate selectivity toward renal cancer and breast cancer subpanels with selectivity ratios of 3.06 and 5.11, respectively, at the cytostatic activity (TGI) level. Compounds 6e and 6d achieved good tubulin polymerization inhibitory activity with IC 50 values of 17 and 40 μM, respectively. The photomicrographs made for compounds 6d and 6e on cellular microtubules indicated that the cytotoxicity of these compounds can be attributed to their ability to interfere with microtubule assembly. Molecular modeling studies involving compound 6e with the colchicine binding site of α,β-tubulin revealed hydrogen-bonding and hydrophobic interactions with several amino acids in the colchicine binding site of β-tubulin. Novel 1-(3',4',5'-trimethoxybenzoyl)-3,5-diarylpyrazoline derivatives were synthesized and evaluated for their cytotoxic properties on different cancer cell lines and their tubulin polymerization inhibitory activity. The cytotoxicity of compounds 6d and 6e can be attributed to their ability to interfere with microtubule assembly. Molecular modeling studies involving compound 6e revealed hydrogen-bonding and hydrophobic interactions with several amino acids in the colchicine binding site of β-tubulin.
机译:合成了一系列新颖的1-(3',4',5'-三甲氧基苯甲酰基)-3,5-二芳基吡唑啉衍生物,并评估了它们对不同癌细胞系的细胞毒性和微管蛋白聚合抑制活性。化合物6d和6e对具有不同微管蛋白聚合抑制活性的不同癌细胞系表现出显着的细胞毒性活性。在细胞抑制活性(TGI)水平上,化合物6d对肾癌和乳腺癌亚组具有中等选择性,选择性比分别为3.06和5.11。化合物6e和6d获得了良好的微管蛋白聚合抑制活性,IC 50值分别为17和40μM。在细胞微管上对化合物6d和6e所作的显微照片表明,这些化合物的细胞毒性可归因于它们干扰微管组装的能力。分子模型研究涉及具有α,β-微管蛋白秋水仙碱结合位点的化合物6e,揭示了与β-微管蛋白秋水仙碱结合位点中的几个氨基酸的氢键和疏水相互作用。合成了新型的1-(3',4',5'-三甲氧基苯甲酰基)-3,5-二芳基吡唑啉衍生物,并评估了它们在不同癌细胞系上的细胞毒特性以及对微管蛋白聚合的抑制活性。化合物6d和6e的细胞毒性可归因于它们干扰微管组装的能力。涉及化合物6e的分子建模研究表明,β-微管蛋白的秋水仙碱结合位点中的几个氨基酸具有氢键键合和疏水相互作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号